Taipei, Taiwan

John Yu

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 59(Granted Patents)


Location History:

  • New Taipei, TW (2016)
  • Taipei, TW (2014 - 2017)
  • La Jolla, CA (US) (2005 - 2023)

Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of John Yu

Introduction

John Yu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research, holding a total of 10 patents. His work focuses on developing novel therapeutic approaches for cancer treatment.

Latest Patents

Among his latest patents is the invention of tandem repeat cancer-targeting peptides for molecular conjugation or engineering and their uses in cancer theranostics. This patent describes an isolated cancer-targeting peptide that includes at least two copies of specific amino acid sequences. Additionally, it discloses a pharmaceutical composition for treating cancer, which contains the isolated cancer-targeting peptide and an anti-cancer agent. Another notable patent involves globo H and related anti-cancer vaccines with novel glycolipid adjuvants. This immunogenic composition includes a glycan conjugate that is crucial for enhancing the immune response against cancer.

Career Highlights

John Yu has worked with esteemed institutions such as Academia Sinica and Chang Gung Memorial Hospital. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Alice L. Yu and Chi-Huey Wong. Their collaborative efforts have further advanced the research and development of innovative cancer therapies.

Conclusion

John Yu's contributions to cancer research through his patents and collaborations highlight his dedication to improving cancer treatment options. His innovative work continues to inspire advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…